Save on your Pandel Prescriptions With the PharmaDerm RxSAVER PROGRAM Save on your Pandel Prescriptions With the PharmaDerm RxSAVER PROGRAM

Register for Your Pandel® Instant Savings*

Enroll Now
PharmaDerm RxSaver Program
If you are 18 or older with private health insurance, you may be eligible to pay as little as $25 on your prescription and refills of Pandel®. See Eligibility and Restrictions below.*
Program details

*Eligibility and restrictions:
1. Limitations apply. 2. Valid only for those with commercial insurance. 3. Not valid if prescriptions are paid in part or in full by any state or federally funded healthcare program. 4. Not valid for cash paying patients who have no commercial insurance or where plan reimburses you for the entire cost of your prescription drug. 5. Offer is not valid where prohibited by law. 6. Valid only for residents of the US and Puerto Rico. 7. This program is not health insurance. 8. Offer may not be combined with any other rebate, coupon, or offer. 9. This card is the property of PharmaDerm, a division of Fougera Pharmaceuticals Inc. and must be returned upon request. 10. Fougera reserves the right to rescind, revoke, or amend the program without notice. 11. Patient certifies responsibility for complying with applicable limitations, if any, or any commercial insurance and reporting receipt of program rewards, if necessary, to any commercial insurer. 12. Acceptance of this card and your submission of claims for the PharmaDerm RxSaver Program are subject to the LoyaltyScript® program Terms and Conditions established by McKesson Corporation. 13. This card has no cash value. 14. This Offer expires on December 31, 2018. For any questions regarding set up, claims transmission, patient eligibility or other issues, call the PharmaDerm RxSaver Program at 1-844-396-8097 (8am-8pm ET, Monday-Friday).

NOTICE
The personal information you supply to us will be shared with and among our business partners to provide you with products, programs, and services that may be of interest to you, to conduct market research, and as provided in our Privacy Statement. Your information may be combined with additional information from this or other programs in which you participate, such as prescription information when you redeem savings cards or vouchers. Please be assured that although we share your personal information with our business partners who work with us on these activities, we do not permit our business partners to use or share your personal information for their own separate marketing purposes. You have the right to unsubscribe at any time by calling 1-844-396-8097.

For further information about PharmaDerm privacy practices, please review our Privacy Policy.

Important Safety Information

This medication is for topical use only. Avoid contact with the eyes. The treated skin area should not be bandaged or otherwise covered or wrapped, unless directed by the physician. Therapy should be stopped when your condition gets better. If no improvement is seen within two weeks, contact the physician.

PANDEL can pass through your skin and cause adrenal gland problems. This is more likely to happen if you use PANDEL for too long, use it with other medicines that contain corticosteroids, apply it on a large area of your skin or apply it on broken skin, cover the treated area, have liver failure, or use it in pediatric patients. Your healthcare provider may do blood tests to check your adrenal gland function during and after treatment with PANDEL. Various hormonal abnormalities, increased blood sugar, and revealing underlying diabetes mellitus can also result from topical corticosteroids passing through your skin. Pediatric patients may be more susceptible to systemic toxicity.

Allergic contact dermatitis (rash) with corticosteroids is usually identified by a failure to heal rather than worsening of the condition, as seen with most topical products not containing corticosteroids. If irritation develops, discontinue PANDEL and institute appropriate therapy.

If you are pregnant or nursing a baby, consult with your physician prior to using this product.

The most frequent adverse reactions include burning, stinging, rash, red, bumpy rash, redness, itching, moderate tingling or prickling feeling, and allergic rash. Local adverse reactions that have been reported with topical corticosteroids include itching, irritation, dryness, folliculitis (swelling of the hair follicles), hypertrichosis (excessive hair growth), acneiform eruptions (acne or rashes resembling acne), hypopigmentation (loss of skin color), perioral dermatitis (rash around the mouth), allergic contact dermatitis (rash), secondary infections, skin atrophy (thinning), striae (lines on the skin), and miliaria (rash due to blocking of the sweat glands, 'prickly heat').

Indication

PANDEL® (hydrocortisone probutate) Cream, 0.1% is a topical prescription medication for the relief of the inflammatory (redness) and pruritic (itching) manifestations of corticosteroid-responsive skin conditions in patients 18 years of age or older.

See Full Prescribing Information for Pandel®.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

Important Safety Information

This medication is for topical use only. Avoid contact with the eyes. The treated skin area should not be bandaged or otherwise covered or wrapped, unless directed by the physician. Therapy should be stopped when your condition gets better. If no improvement is seen within two weeks, contact the physician.

PANDEL can pass through your skin and cause adrenal gland problems. This is more likely to happen if you use PANDEL for too long, use it with other medicines that contain corticosteroids, apply it on a large area of your skin or apply it on broken skin, cover the treated area, have liver failure, or use it in pediatric patients. Your healthcare provider may do blood tests to check your adrenal gland function during and after treatment with PANDEL. Various hormonal abnormalities, increased blood sugar, and revealing underlying diabetes mellitus can also result from topical corticosteroids passing through your skin. Pediatric patients may be more susceptible to systemic toxicity.

Allergic contact dermatitis (rash) with corticosteroids is usually identified by a failure to heal rather than worsening of the condition, as seen with most topical products not containing corticosteroids. If irritation develops, discontinue PANDEL and institute appropriate therapy.

If you are pregnant or nursing a baby, consult with your physician prior to using this product.

The most frequent adverse reactions include burning, stinging, rash, red, bumpy rash, redness, itching, moderate tingling or prickling feeling, and allergic rash. Local adverse reactions that have been reported with topical corticosteroids include itching, irritation, dryness, folliculitis (swelling of the hair follicles), hypertrichosis (excessive hair growth), acneiform eruptions (acne or rashes resembling acne), hypopigmentation (loss of skin color), perioral dermatitis (rash around the mouth), allergic contact dermatitis (rash), secondary infections, skin atrophy (thinning), striae (lines on the skin), and miliaria (rash due to blocking of the sweat glands, 'prickly heat').

Indication

PANDEL® (hydrocortisone probutate) Cream, 0.1% is a topical prescription medication for the relief of the inflammatory (redness) and pruritic (itching) manifestations of corticosteroid-responsive skin conditions in patients 18 years of age or older.

See Full Prescribing Information for Pandel®.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
CLICK TO VIEW SITE

Important Safety Information

This medication is for topical use only. Avoid contact with the eyes. The treated skin area should not be bandaged or otherwise covered or wrapped, unless directed by the physician. Therapy should be stopped when your condition gets better. If no improvement is seen within two weeks, contact the physician.

PANDEL can pass through your skin and cause adrenal gland problems. This is more likely to happen if you use PANDEL for too long, use it with other medicines that contain corticosteroids, apply it on a large area of your skin or apply it on broken skin, cover the treated area, have liver failure, or use it in pediatric patients. Your healthcare provider may do blood tests to check your adrenal gland function during and after treatment with PANDEL. Various hormonal abnormalities, increased blood sugar, and revealing underlying diabetes mellitus can also result from topical corticosteroids passing through your skin. Pediatric patients may be more susceptible to systemic toxicity.

Allergic contact dermatitis (rash) with corticosteroids is usually identified by a failure to heal rather than worsening of the condition, as seen with most topical products not containing corticosteroids. If irritation develops, discontinue PANDEL and institute appropriate therapy.

If you are pregnant or nursing a baby, consult with your physician prior to using this product.

The most frequent adverse reactions include burning, stinging, rash, red, bumpy rash, redness, itching, moderate tingling or prickling feeling, and allergic rash. Local adverse reactions that have been reported with topical corticosteroids include itching, irritation, dryness, folliculitis (swelling of the hair follicles), hypertrichosis (excessive hair growth), acneiform eruptions (acne or rashes resembling acne), hypopigmentation (loss of skin color), perioral dermatitis (rash around the mouth), allergic contact dermatitis (rash), secondary infections, skin atrophy (thinning), striae (lines on the skin), and miliaria (rash due to blocking of the sweat glands, 'prickly heat').

Indication

PANDEL® (hydrocortisone probutate) Cream, 0.1% is a topical prescription medication for the relief of the inflammatory (redness) and pruritic (itching) manifestations of corticosteroid-responsive skin conditions in patients 18 years of age or older.

See Full Prescribing Information for Pandel®.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.